About Quadrant Biosciences
Quadrant Biosciences is a company based in Syracuse (United States) founded in 2015.. Quadrant Biosciences has raised $14.01 million across 9 funding rounds from investors including NIH and HHS. Quadrant Biosciences operates in a competitive market with competitors including Sunbird Bio, BrainSpec, Courtagen, Mursla and Imeka, among others.
- Headquarter Syracuse, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.01 M (USD)
in 9 rounds
-
Latest Funding Round
$3.5 M (USD), Series B
Aug 08, 2023
-
Investors
NIH
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Quadrant Biosciences
Quadrant Biosciences has successfully raised a total of $14.01M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $3.5 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series B — $3.5M
-
First Round
First Round
(14 Apr 2016)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Series B - Quadrant Biosciences | Valuation |
investors |
|
| Sep, 2020 | Amount | Grant - Quadrant Biosciences | Valuation |
investors |
|
| Jan, 2020 | Amount | Series A - Quadrant Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Quadrant Biosciences
Quadrant Biosciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Quadrant Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Quadrant Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Quadrant Biosciences Comparisons
Competitors of Quadrant Biosciences
Quadrant Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sunbird Bio, BrainSpec, Courtagen, Mursla and Imeka, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Web-based MRS platform for brain metabolite analysis is utilized.
|
|
| domain | founded_year | HQ Location |
Provides solutions for neurological and metabolic disorders.
|
|
| domain | founded_year | HQ Location |
Diagnostic devices for cancer detection are developed using nanostructures.
|
|
| domain | founded_year | HQ Location |
MRI-based diagnostic software using AI and diffusion imaging is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Quadrant Biosciences
Frequently Asked Questions about Quadrant Biosciences
When was Quadrant Biosciences founded?
Quadrant Biosciences was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Quadrant Biosciences located?
Quadrant Biosciences is headquartered in Syracuse, United States. It is registered at Syracuse, New York, United States.
Is Quadrant Biosciences a funded company?
Quadrant Biosciences is a funded company, having raised a total of $14.01M across 9 funding rounds to date. The company's 1st funding round was a Series A of $2.3M, raised on Apr 14, 2016.
What does Quadrant Biosciences do?
Quadrant Biosciences develops diagnostic products for brain health, creating evolutionary advancements in concussive assessment and autism detection. The company is developing multiple products with different modalities that address ASD and brain concussion. Their brain function tests comprise of a set of tools for the functional assessment of brain health called ClearEdge Brain Health Toolkit and an Autism screening test. The company is also developing a test for the objective detection of concussion by measuring a set of miRNA markers in the patients saliva.
Who are the top competitors of Quadrant Biosciences?
Quadrant Biosciences's top competitors include Sunbird Bio, Mursla and SyntheticMR.